Events • Members
Mayoly inaugurates a new Representative Office in Vietnam and accelerates its development in Southeast Asia
MAYOLY, French pharmaceutical group and international player in Consumer Healthcare, announces the official inauguration of new representative office.
On the 12th of March 2025, French pharmaceutical group Mayoly celebrated the inauguration of its new representative office in Ho Chi Minh City, reinforcing its long-standing presence in Vietnam. The new office will serve as a strategic liaison, conducting market research and fostering key partnerships to better serve the growing healthcare needs of Vietnamese patients and consumers.
The evening began with a warm welcome, followed by speeches from notable figures. French Consul General Madame Emmanuelle Pavillon-Grosser emphasized the importance of France-Vietnam healthcare ties, while CCIFV Chairman Mr. Thibaut Giroux highlighted Vietnam’s growing market appeal. Mayoly Group CEO Mr. Nicolas Giraud and Vietnam Chief Representative Officer Mr. Mehdi Meftah outlined the company’s vision, focusing on Mayoly’s expertise in healthcare solutions. They also announced a strategic partnership with local distributor Hoang Duc to enhance product availability and innovation in Vietnam.
« The extent of MAYOLY’s international commercial network in Southeast Asia is a key asset for our development. In this region, we now benefit from a long-lasting experience in the country, a newly incorporated Representative office in Vietnam and another Regional Commercial Hub in Singapore.
Our strong and structured presence enables us to grow sustainably, meet the needs of patients and consumers, in order to contribute to the improvement of public health »
says Emmanuel PAINT, EVP Global Sales.
The inauguration event marked a significant milestone in Mayoly’s journey, reinforcing its commitment to Vietnam’s healthcare sector and strengthening economic ties between France and Vietnam. As Mayoly embarks on this new chapter, it looks forward to making a lasting impact on the local healthcare landscape through collaboration, innovation, and expertise.
About Mayoly
MAYOLY is an independent French pharmaceutical group with international footprint that has been growing for over a century, based on three historical areas of expertise: digestive health, dermocosmetics and manufacturing, including internationally recognized expertise in soft capsules. Today, MAYOLY is a key player in public healthcare. With sales of €560 million and growth of 5%, MAYOLY is present in 21 countries and its products are distributed in more than 100 countries around the world. With a strong entrepreneurial DNA and a family-oriented corporate culture that puts people at the center of our values, the 2,200 employees of MAYOLY are passionate, committed and proud to improve the health and well-being of all, to offer a better everyday life to everyone.
